Patient characteristics and hemolytic parameters
| Characteristic . | Patients (n = 23) . | Controls (n = 16) . | P . |
|---|---|---|---|
| Age, y | 26 (21-42) | 33 (24-40) | .37 |
| Male:female | 9:14 | 7:9 | .81 |
| BMI, kg/m2 | 21.2 (20.4-23.9) | 23.5 (21.4-26.6) | .037 |
| Systolic BP, mm Hg | 121 (112-130) | 125 (120-127) | .25 |
| Diastolic BP, mm Hg | 71 (66-77) | 78 (77-82) | .003 |
| MCA, Vmean, cm/s | 79 (69-98) | 69 (55-77) | .021 |
| SpO2, mm Hg | 97 (96-97) | 98 (97-98) | .016 |
| Hemoglobin, g/dL | 9.0 (8.5-9.7) | 12.9 (12.3-14.0) | < .001 |
| Hematocrit, L/L | 0.25 (0.24-0.29) | 0.39 (0.37-0.41) | < .001 |
| Reticulocyte, percentage | 7.8 (6.4-11.3) | 0.9 (0.8-1.6) | < .001 |
| LDH, U/L | 380 (336-469) | 155 (131-171) | < .001 |
| Total bilirubin, mg/dL | 2.7 (2.0-4.5) | 0.7 (0.4-1.7) | .004 |
| Characteristic . | Patients (n = 23) . | Controls (n = 16) . | P . |
|---|---|---|---|
| Age, y | 26 (21-42) | 33 (24-40) | .37 |
| Male:female | 9:14 | 7:9 | .81 |
| BMI, kg/m2 | 21.2 (20.4-23.9) | 23.5 (21.4-26.6) | .037 |
| Systolic BP, mm Hg | 121 (112-130) | 125 (120-127) | .25 |
| Diastolic BP, mm Hg | 71 (66-77) | 78 (77-82) | .003 |
| MCA, Vmean, cm/s | 79 (69-98) | 69 (55-77) | .021 |
| SpO2, mm Hg | 97 (96-97) | 98 (97-98) | .016 |
| Hemoglobin, g/dL | 9.0 (8.5-9.7) | 12.9 (12.3-14.0) | < .001 |
| Hematocrit, L/L | 0.25 (0.24-0.29) | 0.39 (0.37-0.41) | < .001 |
| Reticulocyte, percentage | 7.8 (6.4-11.3) | 0.9 (0.8-1.6) | < .001 |
| LDH, U/L | 380 (336-469) | 155 (131-171) | < .001 |
| Total bilirubin, mg/dL | 2.7 (2.0-4.5) | 0.7 (0.4-1.7) | .004 |
Values are median (interquartile range); values for age are median (range).
BMI indicates body mass index; BP, blood pressure; MCA, middle cerebral artery; SpO2, transcutaneous peripheral oxygen saturation; and LDH, lactate dehydrogenase.